{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:46:59Z","timestamp":1792504019445,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cld.2026.01.011","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:50:38Z","timestamp":1772715038000},"page":"513-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa"],"prefix":"10.1016","volume":"30","author":[{"given":"Mohamed","family":"El-Kassas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Wendy","family":"Spearman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zobair M.","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cld.2026.01.011_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/a-1862-9088","article-title":"Nonalcoholic fatty liver disease: current global burden","volume":"42","author":"El-Kassas","year":"2022","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.cld.2026.01.011_bib2","article-title":"Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021","volume":"7","author":"Feng","year":"2025","journal-title":"JHEP Rep"},{"issue":"10397","key":"10.1016\/j.cld.2026.01.011_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet (London, England)"},{"issue":"Suppl","key":"10.1016\/j.cld.2026.01.011_bib4","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2026.01.011_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jhep.2024.08.011","article-title":"Association of food insecurity with MASLD prevalence and liver-related mortality","volume":"82","author":"Younossi","year":"2025","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2026.01.011_bib6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/liv.15852","article-title":"Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa","volume":"44","author":"Younossi","year":"2024","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.cld.2026.01.011_bib7","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1097\/JS9.0000000000002260","article-title":"Burden and attributable risk factors of non-communicable diseases and subtypes in 204 countries and territories, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"111","author":"Li","year":"2025","journal-title":"Int J Surg"},{"issue":"10","key":"10.1016\/j.cld.2026.01.011_bib8","doi-asserted-by":"crossref","first-page":"e1375","DOI":"10.1016\/S2214-109X(19)30374-2","article-title":"Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: results from the Global Burden of Disease Study 2017","volume":"7","author":"Gouda","year":"2019","journal-title":"Lancet Global Health"},{"issue":"7715","key":"10.1016\/j.cld.2026.01.011_bib9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41586-018-0306-9","article-title":"Acting on non-communicable diseases in low- and middle-income tropical countries","volume":"559","author":"Ezzati","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.cld.2026.01.011_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0289155","article-title":"Prevalence of the metabolic syndrome in African populations: a systematic review and meta-analysis","volume":"18","author":"Bowo-Ngandji","year":"2023","journal-title":"PLoS One"},{"issue":"10481","key":"10.1016\/j.cld.2026.01.011_bib11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2026.01.011_bib12","series-title":"Diabetes Atlas","year":"2025"},{"issue":"11","key":"10.1016\/j.cld.2026.01.011_bib13","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.cgh.2024.05.052","article-title":"Genetics of metabolic dysfunction-associated steatotic liver disease: the state of the art update","volume":"22","author":"Sookoian","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.cld.2026.01.011_bib14","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.14309\/ajg.0000000000003421","article-title":"Social determinants of health associated with metabolic dysfunction-associated steatotic liver disease prevalence and severity: a systematic review and meta-analysis","volume":"120","author":"Abu-Rumaileh","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2026.01.011_bib15","unstructured":"Bank TW (World Bank). Urban population, Africa (SP.URB.TOTL) [Internet]. World Development Indicators. Washington, DC: World Bank; 2024 [cited 2025 August 19]. Available at: https:\/\/data.worldbank.org\/indicator\/SP.URB.TOTL?locations=A918."},{"key":"10.1016\/j.cld.2026.01.011_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/nyas.12433","article-title":"Obesity and the nutrition transition in Sub-Saharan Africa","volume":"1311","author":"Steyn","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.cld.2026.01.011_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3390\/nu3040429","article-title":"The nutrition transition in Africa: can it be steered into a more positive direction?","volume":"3","author":"Vorster","year":"2011","journal-title":"Nutrients"},{"key":"10.1016\/j.cld.2026.01.011_bib18","unstructured":"Roser M, Ritchie H, Rosado P. Food supply [Internet]. Our World in Data; 2013\u20132025 [cited 2025 Sept 11]. Available at: https:\/\/ourworldindata.org\/food-supply."},{"issue":"1","key":"10.1016\/j.cld.2026.01.011_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3350\/cmh.2020.0129","article-title":"The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease","volume":"27","author":"Jennison","year":"2021","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2026.01.011_bib20","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1038\/s41598-021-84344-0","article-title":"Association between food insecurity and key metabolic risk factors for diet-sensitive non-communicable diseases in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"11","author":"Nkambule","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.cld.2026.01.011_bib21","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1152\/japplphysiol.00384.2011","article-title":"Does physical inactivity cause nonalcoholic fatty liver disease?","volume":"111","author":"Rector","year":"2011","journal-title":"J Appl Physiol (1985)"},{"issue":"8","key":"10.1016\/j.cld.2026.01.011_bib22","doi-asserted-by":"crossref","first-page":"e1232","DOI":"10.1016\/S2214-109X(24)00150-5","article-title":"National, regional, and global trends in insufficient physical activity among adults from 2000 to 2022: a pooled analysis of 507 population-based surveys with 5\u00b77 million participants","volume":"12","author":"Strain","year":"2024","journal-title":"Lancet Global Health"},{"issue":"1","key":"10.1016\/j.cld.2026.01.011_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhep.2023.01.026","article-title":"Healthcare and socioeconomic costs of NAFLD: a global framework to navigate the uncertainties","volume":"79","author":"Allen","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2026.01.011_bib24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","article-title":"The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge?","volume":"76","author":"Lazarus","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2026.01.011_bib25","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/j.gastro.2025.02.044","article-title":"Global consensus recommendations for metabolic dysfunction-associated steatotic liver disease and steatohepatitis","volume":"169","author":"Younossi","year":"2025","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2026.01.011_bib26","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"NAFLD nomenclature consensus group. A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.01.011_bib27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL\u2013EASD\u2013EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2026.01.011_bib28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic dysfunction-associated steatotic liver disease","volume":"393","author":"Targher","year":"2025","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"10.1016\/j.cld.2026.01.011_bib29","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.3350\/cmh.2022.0431","article-title":"Identification of high-risk subjects in non-alcoholic fatty liver disease","volume":"29","author":"Stern","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cld.2026.01.011_bib30","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010214","article-title":"Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)","volume":"97","author":"Golabi","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.cld.2026.01.011_bib31","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.cgh.2009.06.007","article-title":"Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Hossain","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2026.01.011_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173499","article-title":"Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States","volume":"12","author":"Le","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cld.2026.01.011_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/a-2253-9181","article-title":"Tailored model of care for patients with metabolic dysfunction-associated steatotic liver disease","volume":"44","author":"El-Kassas","year":"2024","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2026.01.011_bib34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/dci24-0094","article-title":"Metabolic dysfunction-associated steatotic liver disease (masld) in people with diabetes: the need for screening and early intervention. a consensus report of the American Diabetes Association","volume":"48","author":"Cusi","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cld.2026.01.011_bib35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/HEP.0000000000000545","article-title":"A global action agenda for turning the tide on fatty liver disease","volume":"79","author":"Lazarus","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.01.011_bib38","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S2468-1253(21)00296-X","article-title":"Health-care provision and policy for non-alcoholic fatty liver disease in Sub-Saharan Africa","volume":"6","author":"Wendy Spearman","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2026.01.011_bib39","first-page":"128","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD) and viral hepatitis","volume":"10","author":"Wang","year":"2022","journal-title":"J Clin Transl Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2026.01.011_bib40","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1440-1746.2011.06801.x","article-title":"Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients","volume":"26","author":"Machado","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2026.01.011_bib41","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/liv.14369","article-title":"Chronic hepatitis B and non-alcoholic fatty liver disease: conspirators or competitors?","volume":"40","author":"Zhang","year":"2020","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.cld.2026.01.011_bib42","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.3390\/jcm14103422","article-title":"When metabolic dysfunction-associated steatotic liver disease meets viral hepatitis","volume":"14","author":"Hasanoglu","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.cld.2026.01.011_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.2005.069757","article-title":"Steatosis in chronic hepatitis C: why does it really matter?","volume":"55","author":"Asselah","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cld.2026.01.011_bib44","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.3390\/clinpract14060200","article-title":"Metabolic Dysfunction- associated steatotic liver disease in chronic hepatitis C virus infection: from basics to clinical and nutritional management","volume":"14","author":"Gonzalez-Aldaco","year":"2024","journal-title":"Clin Pract"},{"key":"10.1016\/j.cld.2026.01.011_bib45","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cgh.2023.01.001","article-title":"Prevalence and characteristics of non-alcoholic fatty liver disease and fibrosis in people living with HIV monoinfection: a systematic review and meta-analysis","volume":"21","author":"Kalligeros","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2026.01.011_bib46","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.jhep.2024.06.026","article-title":"Inclusive healthcare in light of the new MASLD guidelines: should people living with HIV be screened for liver fibrosis?","volume":"82","author":"Sebastiani","year":"2025","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2026.01.011_bib47","first-page":"791","article-title":"Mapping metabolic dysfunction-associated steatotic liver disease models of care across 17 Middle East and North Africa countries: insights into guidelines, infrastructure, and referral systems","volume":"13","author":"El-Kassas","year":"2025","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.cld.2026.01.011_bib48","article-title":"Editorial: emerging therapeutic approaches for non-alcoholic fatty liver disease","volume":"11","author":"El-Kassas","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.cld.2026.01.011_bib49","article-title":"Hepatocellular carcinoma in Africa: challenges and opportunities","volume":"9","author":"El-Kassas","year":"2022","journal-title":"Front Med (Lausanne)"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326126000115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326126000115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:58:46Z","timestamp":1778878726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326126000115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1089326126000115"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2026.01.011","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2026.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}